Science Explorer Interactive view Map
Company · Mechelen · Belgium

Biocartis (Belgium)

Research works
27
▼ 73% vs 2013–17
Citations
202
7.5 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
34%
world 28%

Not ranked overall: Biocartis (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Biocartis (Belgium)?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Cancer Genomics, Mutational Signatures, Molecular Characterization, Hereditary Syndromes, Microsatellite Instability, Immune Response and Precision Medicine.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Targeted Therapy5▲ 82×2 topics
  2. Cancer Genomics3▲ 234×1 topic
  3. Mutational Signatures3▲ 234×1 topic
  4. Epidemiology3▲ 2.9×14 topics
  5. Molecular Characterization3▲ 59×2 topics
  6. Hereditary Syndromes3▲ 271×1 topic
  7. Microsatellite Instability3▲ 271×1 topic
  8. Immune Response2▲ 13×6 topics
  9. Precision Medicine2▲ 25×2 topics
  10. Antiretroviral Therapy2▲ 30×3 topics
  11. Chemotherapy2▲ 9.7×2 topics
  12. Deep Learning2▲ 3.1×3 topics
  13. Cetuximab2▲ 76×1 topic
  14. KRAS Mutations2▲ 188×1 topic
  15. Vaccine Development2▲ 20×4 topics
  16. Vaccine2▲ 14×5 topics
  17. Clinical Trials1▲ 8.3×3 topics
  18. Medical Imaging1▲ 19×2 topics
  19. ALK Inhibitors1▲ 88×1 topic
  20. EGFR Mutations1▲ 88×1 topic
  21. Gene Expression1▲ 8.1×3 topics
  22. Data Analysis1▲ 14×2 topics
  23. Normalization1▲ 62×2 topics
  24. COVID-191▲ 6.4×2 topics
  25. Immunotherapy1▲ 6.5×6 topics
  26. Machine Learning1▲ 1.97×3 topics
  27. Quantitative1▲ 34×1 topic
  28. Real-Time PCR1▲ 94×1 topic
  29. Chest X-Ray1▲ 149×1 topic
  30. Convolutional Neural Networks1▲ 8.9×1 topic

Which research topics does Biocartis (Belgium) publish most on?

By volume in 2022–2025: Advanced Breast Cancer Therapies, Advanced Biosensing Techniques and Applications, Cell Image Analysis Techniques and Molecular Biology Techniques and Applications.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  2. 2 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
  3. 3 Cell Image Analysis Techniques Biophysics 0 works
  4. 4 Molecular Biology Techniques and Applications Molecular Biology 0 works
  5. 5 Cancer Genomics and Diagnostics Cancer Research 0 works
  6. 6 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  7. 7 Bacterial Infections and Vaccines Microbiology 0 works
  8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  9. 9 CAR-T cell therapy research Oncology 0 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.6%not open66.4%

World: 28% of research is openly available.

with international co-authors45.6%domestic only54.4%

World: 19% is written across borders.

How has Biocartis (Belgium)'s research output changed?

Output in 2018–2022 was 73% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Mechelen

All research institutions in Mechelen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.